Cardinal Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jason Hollar
- Full Time Employees
- 57,700
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 7000 Cardinal Place Dublin OH United States of America 43017
- IPO Date
- Aug 4, 1983
- CIK
- 0000721371
- Website
- cardinalhealth.com
- Similar Companies
- Business
- Cardinal Health, Inc. (NYSE: CAH) provides integrated healthcare services and products, distributing pharmaceuticals and medical supplies to hospitals, pharmacies, and healthcare providers worldwide. The company manufactures branded and private-label medical, surgical, and laboratory products, including masks, gloves, gowns, and exam apparel under brands such as Aspen Surgical, Cardinal Health, and Trudell; offers nuclear pharmacy services, patient safety solutions, and pharmacy management software; and operates through three main segments: Pharmaceutical, Medical, and Home Health & Hospice. Its product portfolio encompasses over 20,000 national brand pharmaceuticals, over 2,000 generic drugs, and a broad range of medical-surgical supplies like needles, syringes, IV sets, and wound care items; services include third-party logistics, specialty pharmaceutical distribution, and proprietary navigation technology for at-home care. Cardinal Health serves independent retail pharmacies, chains, hospitals, ambulatory surgery centers, clinical laboratories, and physician offices primarily in the United States, Canada, and Puerto Rico, with headquarters in Dublin, Ohio, where it was founded in 1971. In recent developments, Cardinal Health completed the acquisition of Integrated Pharmacy Solutions in October 2024, expanding its 503A sterile compounding capabilities to support hospital pharmacies nationwide; launched a new Advanced Call Center in July 2024 to enhance customer service for its Medical segment; and announced a strategic distribution agreement with the Novo Nordisk Patient Assistance Program (PAP) in November 2024 to broaden access to essential medications. The company also secured a five-year Pharmaceutical Supply Agreement with the U.S. Department of Veterans Affairs in September 2024 valued at approximately $9.3 billion, reinforcing its position as a key government supplier; introduced the Cordless Navigation System for orthopedic procedures in 2024; and completed the divestiture of its Health Care Compliance business to RLDatix in December 2024. These moves reflect ongoing efforts to optimize operations, grow in high-margin areas like sterile compounding and navigation technology, and strengthen partnerships amid supply chain challenges.
Cardinal Health Expands Home Care Business With Two Acquisitions
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note
Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million
Cardinal Health expands home care business with two tuck-in acquisitions
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice
5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds
Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
Should You Retain CAH Stock After Removal From Several Russell Indices?
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term